Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period. - Braun, J; Deodhar, A; Dijkmans, B (Arthritis Rheum, 2008)
et al.